Name:2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose;Tetra-O-benzyl-D-glucopyranose; 2,3,4,6-Tetrakis-O-(phenylmethyl)-D-glucopyranose.
Molecular formula: C34H36O6
Molecular weight:540.66
CAS#:4132-28-9
Molecular structure:
Specification:
Item | Specification |
Appearance Assay (HPLC), % Melt point, ℃ Specific Rotation [α], ° Loss of dry, % Ash (residue on ignition), % Heavy metal, ppm As, ppm TLC | White to offwhite powder or crystalline solid ≥98 145~151 15.5~22(C=1,CHCl3) ≤1.0 ≤0.1 ≤10 ≤1 Single spot |
Characteristics:
It is a white to offwhite powder or crystalline solid. Insoluble in water,slightly soluble in dioxane and soluble in toluene etc.
Uses:
This product is an important derivant of D-glucopyranose, it is used for pharmaceutical intermediates and used in biochemical reactions and other chemical reactions.
As a pharmaceutical intermediate, for example, used in synthetize derivants of 3-position glycosylation for anti-Alzheimer disease, synthetize carbohydrate complexes of sulfate/ phosphate and glycoside derivatives of indolopyrrolocarbazole for treatment cancer, synthetize compounds of perfluoroalkyl-containing sugar radicals for diagnosis of cancer, synthetize Voglibose, nojirimycin and its derivants, glucose ester of glycyl-propionic acids for cure diabetes, and synthetize other pharmaceuticals such as polysaccharide, glycosylations derivatives with benzotriazole/ nitrophenyl and phospholipid-saccharide conjugates for treatment sepsis, meningitis, AIDS, osteoporosis, osteitis deformans or Paget’s diease etc.
Used in prepare 1-halogenation glucopyranose and synthesis other derivatives of 1- C-alkyl or glycosides -α-d-glucopyranosides, and so on. Moreover, the compound of 2,3,4,6-tetra-O-benzyl-1-C-vinyl-α-D-glucopyranose conjugate with 15-crown-5 ether is a novel chiral phase-transfer catalysts
Storage:
Maintain in cool, dry containment.
Package:
20kg/drum or as customer require.
Expiration Date: 2 years